Imaging TB infection with a new tracer
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study uses a special PET/CT scan with a new tracer to see how TB infection looks in the lungs. It may help doctors better understand and treat TB.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years or older.
- You have TB confirmed by a lab test (culture or PCR).
- You are on or can start standard TB treatment.
- You have cavities (holes) in your lungs seen on a chest X-ray.
- You are not pregnant or breastfeeding, and can have imaging scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan (called FAPI-74) to see if it can detect fibrosis (scarring) in the lungs of people with active TB. It looks at the scan both at the start of treatment and after 6 months of therapy to understand how the lungs heal.
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This study tests whether a new PET/CT scan using a radioactive tracer called FAPI-46 can better see lung changes in people with interstitial lung disease. It might help doctors understand the disease activity better.
Hear when a new Tuberculosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.